Positive PD-L1 expression was found in 255 (36%) out of 709 T3–4 level tumour invasion patients, while 116 (23.1%) out of 502 T1–2 level tumour invasion patients were PD-L1 expression positive. This evidence concerns the gene CD274 and neoplasm.